ENHERTU® (fam-trastuzumab deruxtecan-nxki) Approved in the US for the Treatment of Patients with Previously Treated HER2-Positive Advanced Gastric Cancer
First HER2-directed medicine approved for patients with gastric cancer in a decade WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca and Daiichi Sankyo Company, Limited…